Genetic Breakthrough at OHSU
By Allison Frost,
Oregon Public Radio
| 10. 29. 2012
[With CGS's Marcy Darnovsky]
Oregon Health and Science University scientist Shoukhrat Mitalipov and his team have created a viable embryo with the genetic material from three different parents. The goal is to prevent genetic diseases from being passed down.
We spoke to Mitalipov in 2009 after baby rhesus macaque monkeys were born using the same science. Now that human genetic material has been used in a similar way, we'll check back in with the research team and an ethicist to discuss the implications of this scientific breakthrough.
Here's a video that shows how Mitalipov's team removed much of the genetic material from one woman's egg and put it into another:
What questions do you have about the medical or ethical implications of this research?
Related Articles
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...